CSI Market
Sign In | Register

Dicerna Pharmaceuticals Inc (DRNA) Annual Balance Sheets

Annual · GAAP · USD millions
Access DRNA quarterly Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Dicerna Pharmaceuticals Inc manages assets, liabilities, and equity through different cycles.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2020)
(Dec 31 2019) (Dec 31 2018) (Dec 31 2017) (Dec 31 2016)
Assets
Cash & cash equivalent126.02
Restricted Cash and Cash Equivalents, Current0.74
Held-to-maturity Securities, Current MA3442.82
Cash & Short-term Investments568.00
Accounts receivable34.71
Other Current Assets0.00
Prepaid Expense And Other Assets Current14.40
Total Current Assets618.70
Equipment/Property/Plant Net0.00
Long-term investments5.62
Other Assets, Noncurrent24.00
Operating Lease Right Of Use Asset60.84
Total Assets707.85
Liabilities
Accounts Payable, Current AC7.90
Accrued Liabilities And Other Liabilities28.06
Estimated Litigation Liability, Current0.00
Other Liabilities, Current141.98
Deferred Revenue, Current DE0.00
Total Current Liabilities177.94
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE6.00
Deferred Revenue, Noncurrent DE0.00
Other liabilities, Noncurrent386.15
Contract With Customer Liability Current138.54
Contract With Customer Liability Noncurrent336.24
Total Liabilities570.09
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock775.81
Retained Earnings / Accumulated Deficit-638.06
Other Equity0.00
Common Stockholder's Equity137.75
Total Stockholder's Equity137.75
Liabilities & Stockholder's Equity707.85
4 historic quarters locked

Sign in to unlock the full Dicerna Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About DRNA Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License